These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11346074)

  • 41. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recall urticaria induced by skin tests with heparin.
    Weber HO; Fischer J; Kneilling M; Caroli U; Rocken M; Biedermann T
    Br J Dermatol; 2009 Jul; 161(1):187-9. PubMed ID: 19438465
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.
    Tvito A; Bakchoul T; Rowe JM; Greinacher A; Ganzel C
    Am J Hematol; 2015 Jul; 90(7):675-8. PubMed ID: 25683147
    [No Abstract]   [Full Text] [Related]  

  • 45. Dalteparin--another low-molecular-weight heparin.
    Med Lett Drugs Ther; 1995 Dec; 37(963):115-6. PubMed ID: 7500910
    [No Abstract]   [Full Text] [Related]  

  • 46. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dalteparin new treatment duration: new dosage. Is prolonged prophylaxis needed?
    Prescrire Int; 2000 Feb; 9(45):197-8. PubMed ID: 11503794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ongoing intracerebral bleeding despite hemostatic treatment associated with a spot sign in a patient on oral anticoagulation therapy.
    Rizos T; Rohde S; Dorner N; Steiner T
    Cerebrovasc Dis; 2009; 28(6):623-4. PubMed ID: 19887792
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute generalized exanthematous pustulosis from dalteparin.
    Komericki P; Grims R; Kränke B; Aberer W
    J Am Acad Dermatol; 2007 Oct; 57(4):718-21. PubMed ID: 17610994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dalteparin dosing in high-flux haemodialysis and haemodiafiltration.
    Sridharan S; Berdeprado J; Sivalingam M; Farrington K
    Nephron Clin Pract; 2012; 122(1-2):53-7. PubMed ID: 23548465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
    Koch P; Reinhold S; Busch C
    Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hematoma of the rectus muscle of abdomen in a patient treated with nadroparin].
    Pessina I; Bocchia M; Giansante P; Vaghi A
    Recenti Prog Med; 2003; 94(7-8):321-2. PubMed ID: 12868238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reporting the NAFT major bleeding rates in context: reviewers should include site investigator-classified rates.
    Hull RD; Mah AF
    Arch Intern Med; 2003 Feb; 163(3):369; author reply 369. PubMed ID: 12578520
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticoagulants, iliopsoas hematoma and femoral nerve compression.
    Niakan E; Carbone JE; Adams M; Schroeder FM
    Am Fam Physician; 1991 Dec; 44(6):2100-2. PubMed ID: 1746390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Forearm compartment syndrome after diazepam administration.
    Bortolussi ME; Hunter JG; Handal AG
    Anesthesiology; 1991 Jul; 75(1):159-60. PubMed ID: 2064046
    [No Abstract]   [Full Text] [Related]  

  • 57. [Acute compartment syndrome secondary to an intravenous injection of heroin in a drug abuser: report of a case].
    El Alaoui A; Bah A
    Pan Afr Med J; 2015; 22():349. PubMed ID: 26985267
    [No Abstract]   [Full Text] [Related]  

  • 58. Retropharyngeal hematoma: a complication of anticoagulant therapy.
    Hamasni CM
    J Med Liban; 2001; 49(6):351-4. PubMed ID: 12744640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spontaneous hemothorax following anticoagulation with low-molecular-weight heparin.
    Ganguli A; Walker L; FitzGerald RJ; Pirmohamed M
    Ann Pharmacother; 2009 Sep; 43(9):1528-31. PubMed ID: 19690222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hematoma of the abdominal wall secondary to use of low molecular weight heparin].
    Yusty Campo M; Lado Lado FL; Pérez Herbón M; Rodríguez Constenla I; Rodríguez López I
    An Med Interna; 2003 May; 20(5):273-4. PubMed ID: 12831308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.